Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Bullboard Posts
Post by MoneyStockon Jun 12, 2019 2:45pm
188 Views
Post# 29819429

IR news update - I am sure HUGE is in Right Track

IR news update - I am sure HUGE is in Right TrackAs we get any financial news, then HUGE will be close to $1.00 soon.

Good Afternoon,
We know of no specific reason for the share weakness. We continue to focus on things we can control- scaling our operations, investing in the business, reducing our cost of capital, hiring highly qualified people, research and development, developing the facility and continue to accomplish more milestones this calendar year. 
 
During these periods, keep in mind of the original thesis of the company and the value we have created going forward. Yes, It’s only management announcements recently but these are highly qualified doctors with outstanding track records and have joined FSD Pharma with each of their own intent to accomplish within the company. FSD Pharma’s strategic partnerships position the company to execute on several divisions of the cannabis industry:
  • Retail investments:  High Tide & Huge Shops
  • Extractions: World Class Extractions
  • Supply agreements: Aura health to establish distribution channel in Germany & Eurozone
  • CBD consumption products: Canntab Therapeutic’s hard pill CBD tablet, and Pharmastrip
  • Research & Development: Scicann Therapeutics, Prismic Pharmaceuticals, and Solarvest
  • Cultivation partnership with Cannara Biotech
Best Regards,
IR FSD Pharma
Bullboard Posts